About UO Immunoterapia e laboratorio TCS, IRST IRCCS
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at UO Immunoterapia e laboratorio TCS, IRST IRCCS
During the past decade, UO Immunoterapia e laboratorio TCS, IRST IRCCS conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at UO Immunoterapia e laboratorio TCS, IRST IRCCS
According to Clinical.Site data, the most researched conditions in "UO Immunoterapia e laboratorio TCS, IRST IRCCS" are
"Adjuvant Drug Therapy" (1 trials), "Malignant Melanoma" (1 trials), "Malignant Melanoma of Skin Stage III" (1 trials), "Malignant Melanoma of Skin Stage IV" (1 trials) and "Vaccin Therapy" (1 trials). Many other conditions were trialed in "UO Immunoterapia e laboratorio TCS, IRST IRCCS" in a lesser frequency.
Clinical Trials Intervention Types at UO Immunoterapia e laboratorio TCS, IRST IRCCS
Most popular intervention types in "UO Immunoterapia e laboratorio TCS, IRST IRCCS" are "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Autologous Dendritic Cell vaccine" (1 trials), "arm 1: DC Vaccine + RT" (1 trials), "arm 2: DC Vaccine + IFN-alfa" (1 trials), "arm 3: both arm 1 and 2 + RT" (1 trials) and "arm 4: DC Vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UO Immunoterapia e laboratorio TCS, IRST IRCCS
The vast majority of trials in "UO Immunoterapia e laboratorio TCS, IRST IRCCS" are
2 trials for "All" genders.
Clinical Trials Status at UO Immunoterapia e laboratorio TCS, IRST IRCCS
Currently, there are NaN active trials in "UO Immunoterapia e laboratorio TCS, IRST IRCCS".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in UO Immunoterapia e laboratorio TCS, IRST IRCCS,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in UO Immunoterapia e laboratorio TCS, IRST IRCCS, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".